As of November 2026 Lyell Immunopharma has a market cap of โน34.77 Billion. This makes Lyell Immunopharma the world's 8088th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
On Nov 9th, 2026 the market cap of Lyell Immunopharma was reported to be: